Within tumor tissue, lung CD8 + TRMs also display high levels of cytotoxic effector molecules, proliferation and express high levels of co-inhibitory markers PD-1, CTLA-4, LAG-3 and Tim-337,39,46, making them attractive targets for checkpoint inhibitor therapy. This evidence concerns the gene CD8A and neoplasm.